Periodical information
三才期刊采编系统
Acquisition System
（1993年创刊 半月刊）
Sponsors
Chinese Anti-cancer Association
Shaanxi Anti-cancer Association of China
Shaanxi Cancer Institute 
Editing & Publishing
Editorial Board of Journal of Modern Oncology
309 Yanta West Road Xi＇an Shaanxi Province 710061, P.R.China
Tel：0086-029-85578876
0086-029-85277356
0086-029-85276012
Fax:0086-029-85277356
http://www.xdzlyx.com/
E-mail：sxzlyx@263.net
Chief of Magazine Agency
Geng Qingyi(耿庆义)
Editor-in-Chief & Managing Director
Li Shuye(李树业)
Honorary editor in chief
Fan Daiming(樊代明)
Hao Xishan(郝希山)
Subscriptions
Domestic
Local Post Offices,China Post subscription code 52-297
Overseas
China International Book Trading Corporation
P.O.Box 399,Beijing 100044,China. Code No：M1985
Licence for Advertising
Shaanxi Industrial Commer-cial:6100004000094
Printing
Printing Branch of Xi＇an Haoxuan printing Co.Ltd 
CSSN
ISSN 1672-4992
CN 61-1415/R
Price
RMB ￥10.00
US $6.00
Journal introduction
  
    "Modern Oncology" (ISSN1672-4992, CN61-1415/R, semimonthly publication) is a nation-level domestic and foreign public released oncology periodical, proved by "Ministry of Chinese Science and Technique" and "News Publication Administration", also is one of the series periodicals of Chinese Anti-cancer Association. The journal is sponsored by Chinese Anti-cancer Association, Shaanxi Anti-cancer Association of China, Shaanxi Cancer Institute, Shaanxi Medical Academy of China and is managed by Shaanxi Scientific Technical Association. This journal is included by "Source Journals for Chinese Scientific and Technical Papers and Citations", "Chinese Scientific and Technical Core Periodical","A Guide to the Core Journals of China" , "Chemical Abstracts of USA", "Japan Science and Technology Agency(Chinese Bibliographic Database), JST China”， "Chinese Journal Net", "Chinese Academic Journal (CD-ROM Version) Full Text Database", "China Core Journals (Selection) Database", "Chinese Biomedical Literature Database", also is the full text internet journal of "Wanfang Data-Digital Periodical ", the source journal of "China Abstracts of Academic Periodicals"and "Chinese Medical Abstract•Oncology".更多...
Current Issue: 2023,Vol.31,NO.13
[2373-2378] Activation of osteoclasts on dormant lung adenocarcinoma cells and its molecular mechanism
[GUI Pengcheng1,2,QIU Rong2,WEI Lirong2,TENG Xiaoyan2,DU Yuzhen1,2]
2023 13 [Abstract]()
[2379-2384] Radiosensitization of breast cancer cells and transplanted tumors by folate-modified halloysite nanotubes loaded with curcumin
[WANG Hanjian1,2，HAN Dongliang2,WEI Wenxiang1,TIAN Weiqun1]
2023 13 [Abstract]()
[2384-2388] IL-17A promotes the proliferation,migration and invasion of lung cancer A549 cells through PI3K/Akt pathway
[WANG Hongkai1,2,TANG Hao1,ZHU Shida1,CHEN Kai1,YUAN Shujie1，HU Junzu1,2]
2023 13 [Abstract]()
[2389-2394] Effect of overexpression of lnc-TNFAIP3 gene on biological behavior of pancreatic cancer PANC-1 cells
[HU Xianhua1,ZHANG Rendan2,YAO Jiaxin1,ZHAO Chunyan3,MU Bo4]
2023 13 [Abstract]()
[2395-2400] Expression of KDM3A in tissues and cells of colorectal cancer and its effect on proliferation,invasion and migration of cancer cells
[LUO Zhipeng,MIAO Zhiguo,WEI Haiyun]
2023 13 [Abstract]()
[2400-2405] CPNE7 affects the proliferation,migration and invasion of gastric cancer cells through epithelial-mesenchymal transition
[XIA Tianhong1,2,YUAN Shaobin2，CAO Xiaomeng2,GUO Changan3,WANG Wenjie4,LIU Hongbin1,2]
2023 13 [Abstract]()
[2405-2411] Effect and mechanism of Yiyi Fuzi Baijiang San combined with electroacupuncture on colitis-associated colorectal cancer in AOM/DSS mice
[YAN Minyu1，2，LI Bingrong2，JIANG Juntao3，LIU Peng2，YUAN Long2，GENG Zixiang2，LING Lele2，LI Zan4，SUI Hua4，ZHANG Bimeng1，2]
2023 13 [Abstract]()
[2412-2417] The mechanism of Tie-2 in the process of oral squamous cell carcinoma invading the jaw
[AI Mengsheng1,SHEN Yang1,GAO Mingyu1,ZHANG Qinghua1,FEI Wei1,2]
2023 13 [Abstract]()
[2417-2424] Impact of CircCSNK1G1 on the malignant biological behavior of laryngeal cancer cells by regulating the miR-381-3p/bromine domain protein 4(BRD4) axis
[DONG Jing,CHEN Xianquan]
2023 13 [Abstract]()
[2425-2430] Influences of LncRNA FENDRR on the proliferation,epithelial-mesenchymal transition and invasion of esophageal cancer cells by regulating the expression of miR-942-5p
[YANG Hailong1,WANG Dingding1,CHEN Yutong1,CHEN Xiaowei1,LI Bing1,WANG Xinli2]
2023 13 [Abstract]()
[2431-3437] Study on the mechanism of miR-335-5p regulating the immune escape of prostate cancer cells through targeted regulation on Galectin-3
[ZHOU Rubao,GUO Zonghua,YANG Jun,XU Wei,ZHAO Kedong,RAO Zhigang,KONG Dongbo,JIANG Botao]
2023 13 [Abstract]()
[2437-2442] PTPRJ promotes the adhesion,migration and invasion of prostate cancer cells through Src/PI3K/Akt signaling pathway
[ZHU Baoan1，ZHENG Jianxin2，ZHANG Yinpo3]
2023 13 [Abstract]()
[2443-2447] Corralation between metabolic symdrome and the occurrence and severity of differentiated thyroid carcinoma
[HE Qingyuan1,YAN Huiming2]
2023 13 [Abstract]()
[2448-2454] PAK2 promotes cisplatin resistance in lung cancer cells by regulating the activity of ERK signaling pathway
[WANG Shuang1,RONG Xuezhu2,WANG Si3,LI Zhen2,LIU Yang2]
2023 13 [Abstract]()
[2455-2462] The role of miRNA-4295/ST18 axis in the occurrence of breast cancer and its clinical value for early screening and diagnosis of breast cancer
[XU Yanmin,ZHANG Lingling,MA Xiufeng]
2023 13 [Abstract]()
[2463-2466] Application of rubber band traction assisted technique in endoscopic submucosal dissection of early esophageal cancer
[XIE Wenfu,WEI Mingyong,SHI Xiaoqiong,PENG Xue,HE Meilin,SHU Qiao]
2023 13 [Abstract]()
[2467-2471] Expression of forkhead box protein 3(Foxp3) in gastric stromal tumors and its clinicopathological significance
[WU Zhaoying,XIE Hao,ZOU Junwei,ZHANG Lei,HUANG Yong]
2023 13 [Abstract]()
[2472-2475] Evalution of eosinophil level after treatment in predicting the efficacy and prognosis of patients with pancreatic cancer treated with anti-PD-1 antibody therapy(2 cases)
[LU Changchang1,DU Juan1,2,MENG Fanyan2]
2023 13 [Abstract]()
[2475-2480] Expression and clinical significance of YAP and Src in gastric cancer tissues
[CAI Jiahui1,TAO Fei2]
2023 13 [Abstract]()
[2481-2486] Clinical analysis of 9 cases of internal abdominal hernia after radical gastrectomy for gastric cancer
[DUAN Shuquan，SUO Lingyu，JIN Guoliang，WANG Zengyang，HAN Weijie，ZHENG Liansheng，WANG Qiuhong，LIU Lin]
2023 13 [Abstract]()
[2486-2490] The expression of IL28RA in gastric cancer tissue and its relationship with clinical pathological features and prognosis
[SU Chen,ZHANG Guoshan,PAN Jiachao,ZHENG Yawen]
2023 13 [Abstract]()
[2491-2496] The expression of PIM1 in diffuse large B-cell lymphoma tissue with co-expression of C-MYC/BCL2 and its relationship with clinicopathological characteristics
[XU Ruihuan，XU Juan，YANG Wenxiu]
2023 13 [Abstract]()
[2496-2501] The value of baseline 18F-FDG PET/CT imaging in the distribution,grading and staging of follicular lymphoma
[ZHANG Huan1,2,HU Bin1,3，HE Liu1,2,GU Cheng1,ZHANG Xiaoming1,ZHENG Lichun1]
2023 13 [Abstract]()
[2508-2512] Analysis on the incidence,death and survival trend of thyroid cancer among urban residents in Shenyang，China from 2009 to 2019
[LYU Yi1,ZHANG Xinyu2,NIE Huifang1,ZHAO Xue1,LI Xun1,WANG Xiaoli1]
2023 13 [Abstract]()
[2512-2518] Research progress of m6A-RNA methylated YTHDF1 binding protein in glioma
[ZHU Lin,YU Tao,ZHENG Fakang,GONG Haidong]
2023 13 [Abstract]()
[2519-2522] Research progress on the improvement of ALC/AMC ratio in DLBCL treated with lenalidomide combined with R-CHOP
[HOU Yangyang，LIU Aichun]
2023 13 [Abstract]()
[2522-2526] Research progress on ferroptosis in the treatment of urinary tract tumors
[GAO Sheng，MIAO Bailiang，MO Qizhou，ZHAO Yuwan，LIU Jianjun]
2023 13 [Abstract]()
[2527-2533] The role of RBP2 and its selective inhibitors in tumor
[LU Zijun1,FENG Tongfu2]
2023 13 [Abstract]()
[2533-2536] Synthetic biology and cancer therapy
[ZHANG Baihong1,YUE Hongyun2]
2023 13 [Abstract]()
[2536-2540] Research progress on the mechanism of drug resistance of the third generation EGFR-TKIs and the fourth generation EGFR inhibitors
[CHEN Yuan，LIU Lingshuang]
2023 13 [Abstract]()
[2541-2545] Research progress on abnormal DNA methylation in the occurrence,development,diagnosis and treatment of prostate cancer
[GU Jun，CHEN Zhenjie，HE Zexi，WANG Haifeng，WU Haichao，LIN Jiawei，DING Mingxia]
2023 13 [Abstract]()
[2546-2552] Research progress of immune checkpoint inhibitor therapy-immune-related venous thromboembolic events
[LI Huimin,LI Hong,LUO Qin]
2023 13 [Abstract]()
[2552-2557] Research progress of the relationship between serum response factor and tumor
[ZHENG Axiu1,YUAN Jianling1，LUO Botao1,JIE Wei1,2]
2023 13 [Abstract]()
[2557-2562] Research progress on anti-tumor effect of TNBG and its derivatives
[CHEN Jiezhong1,ZHENG Xiaohong2,YU Yu3]
2023 13 [Abstract]()